Back to Market Feed

RELAFEN DS 1,000 MG TABLET

$31.6667per EA

High Outlier

Strength

1000 mg/1

Manufacturer

CarWin Pharmaceutical Associates LLC

NDC

15370017030

Classification

Brand (ANDA)

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

Approval Type

Generic (ANDA)

FDA Application

On Market Since

9/20/2019

Pharmacological Classes

Anti-Inflammatory Agents

Non-Steroidal

Cyclooxygenase Inhibitors

Nonsteroidal Anti-inflammatory Drug

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

1 alternative • Same active ingredient

RELAFEN DS 1,000 MG TABLET

15370017060•CarWin Pharmaceutical Associates LLC

Related Drugs

Same classification

DOLOBID 250 MG TABLET

74157000960•INA Pharmaceutics Inc